Grasim Industries Limited has announced the grant of 2,676 stock options to eligible employees under its Employee Stock Option and Performance Stock Unit Scheme 2022. The Nomination and Remuneration Committee of the Board of Directors approved this grant during its meeting held on February 10, 2026.

Stock Option Grant Details

The total grant comprises two distinct categories of stock options allocated to eligible employees:

The scheme operates through the Grasim Employees' Welfare Trust and complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Pricing Structure

The exercise prices for the two categories of stock options differ significantly:

The ESOP exercise price of Rs. 2,926.30 per option is based on the market price as of February 9, 2026, in accordance with applicable SEBI regulations.

Vesting and Exercise Terms

The scheme features distinct vesting schedules for different option types:

ESOP Vesting:

• 33% vesting each year over three years
• First vesting occurs after completion of one year from grant date

PSU Vesting:

• 100% vesting at the end of three years from grant date

Exercise Period:

• Stock options must be exercised within five years from the date of vesting
• All ESOPs and PSUs are subject to performance conditions for vesting

Regulatory Compliance

The grant was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed BSE Limited (Scrip Code: 500300) and National Stock Exchange of India Limited (Symbol: GRASIM) about this development. The scheme aligns with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, ensuring regulatory compliance for the employee benefit program.

Grasim Industries Limited announced that its Board of Directors has approved the re-appointment of two Independent Directors for second terms during a meeting held on February 10, 2026. The board meeting, which commenced at 3:25 p.m. (IST) and concluded at 5:24 p.m. (IST), addressed key governance appointments based on the Nomination and Remuneration Committee's recommendations.

Board Appointments Overview

The board approved the re-appointment of Mr. V. Chandrasekaran (DIN: 03126243) and Mr. Adesh Kumar Gupta (DIN: 00020403) as Non-Executive Independent Directors for a second term of five consecutive years. Both appointments are subject to shareholder approval and will be effective from May 24, 2026 to May 23, 2031.

Director Profiles and Expertise

Mr. V. Chandrasekaran

Mr. V. Chandrasekaran is a qualified Chartered Accountant and retired Executive Director (Investment) of LIC of India. He brings more than three decades of experience in Life Insurance Finance, Housing Finance and Mutual Fund Investment, with adequate exposure to a gamut of investments. His expertise encompasses investment decision making processes, investment monitoring and accounting, and investment research and risk management.

He currently serves as an Independent Director on the boards of various companies including UltraTech Cement Limited, Aditya Birla Housing Finance Limited, CARE Ratings Limited, Tata Investment Corporation Limited, and Aseem Infrastructure Finance Limited.

Mr. Adesh Kumar Gupta

Mr. Adesh Kumar Gupta is a qualified Chartered Accountant and Company Secretary who has completed the Advanced Management Programme from Harvard University. He possesses more than four decades of vast experience in finance and general management, with sound knowledge and expertise in finance, strategy and corporate law across various industries.

Notably, he served as the Whole Time Director and CFO of Grasim Industries until June 30, 2015. His achievements include recognition as Best CFO by the Institute of Chartered Accountants of India, IMA, and Business Today. He was also an Ex-Member of the National Advisory Committee on Accounting Standards (NACAS) as representative of FICCI, a statutory organisation constituted by the Government of India for setting up Accounting Standards.

Currently, he serves as an Independent Director on the boards of Krsnaa Diagnostics Limited, Anand Rathi Home Finance Limited, Anand Rathi Financial Services Limited, and Anand Rathi Wealth Limited.

Regulatory Compliance

The appointments comply with Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. Both directors are not debarred from holding the office of Director by virtue of any SEBI order or order of any other authority, and neither is related to any Director on the Board or Key Managerial Personnel of the Company.

The company has communicated these appointments to BSE Limited (Scrip Code: 500300), National Stock Exchange of India Limited (Symbol: GRASIM), Luxembourg Stock Exchange, and relevant custodial services as per regulatory requirements.